Cargando…
Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome
The global pandemic of SARS-CoV-2 has been known to have diverse neurologic complications among adult patients. The neurologic effects of SARS-CoV-2 in the pediatric population is poorly described, especially in those with rare underlying neurologic conditions. We describe the first known case of SA...
Autores principales: | Wiegand, Sarah E., Mitchell, Wendy G., Santoro, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899919/ https://www.ncbi.nlm.nih.gov/pubmed/33677410 http://dx.doi.org/10.1016/j.msard.2021.102855 |
Ejemplares similares
-
Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient
por: Vale, Thiago Cardoso, et al.
Publicado: (2013) -
Opsoclonus – Myoclonus syndrome induced by phenytoin intoxication
por: Verma, Rajesh, et al.
Publicado: (2014) -
Opsoclonus-myoclonus syndrome after adenovirus infection
por: Syrbe, Steffen, et al.
Publicado: (2015) -
Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome
por: Santoro, Jonathan D., et al.
Publicado: (2021) -
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective
por: Rossor, Thomas, et al.
Publicado: (2022)